notundesh24.com : The United States paid NovaVax 1.6 billion to develop the vaccine
The US government has allocated 1.6 billion to NovaVax Inc. for testing and commercial production of a possible coronavirus vaccine. The allocation is aimed at producing and supplying 100 million doses of potential vaccines to the United States by next January.
This is the largest allocation given to an organization by the US government under a project adopted by the White House to discover a vaccine against Covid-19.
“The allocation will be released at the beginning of the last quarter of this year (October-December),” NovaVax chief executive Stanley Arc told Reuters. This allocation has been made to make 100 million doses of possible vaccines.
The Reuters report said the US government’s allocation would also be spent on the third phase of human testing. This wide range of human experiments will start from next October.
Novavax began human testing of a possible vaccine by the end of last May. The results of their first-stage test will be available next week, said Stanley Ark. The company plans to start the second phase next month and the third phase in October. Stanley Arc claims that the vaccine they have developed has shown good results so far.